Komori
Daishin Chemical (4629) · RiskSoftened

Impact of COVID-19 on Business Activities and Performance

First written in FY2020. 4 of 13 entries say "Restated". Latest entry: FY2024.

13entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2021-Q1 – FY2021RestatedFY2022 – FY2023-Q3SoftenedFY2023 – FY20242020: 320202021: 220212022: 320222023: 420232024: 12024
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1254 companies write about · 1266 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1280 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024SoftenedAnnual report

    「Although the reclassification of COVID-19 as a Category 5 infectious disease eased restrictions on activities and economic activity moved toward normalization through increased personal consumption and inbound demand, among other factors, a gradual recovery trend is emerging,」

    The company describes the reclassification as a Category 5 infectious disease, the easing of restrictions on activities and the normalization of economic activity, further weakening the expression of COVID-19's impact on business activities.
  2. FY2024-Q2SoftenedAnnual report

    「Although Japan’s economy during the cumulative second quarter showed signs of a gradual recovery as the reclassification of COVID-19 as a Category 5 infectious disease led to the easing of restrictions on activities and overseas travel, among others, and economic activity in areas such as dining out, accommodation and entertainment moved toward normalization,」

    The company describes the reclassification as a Category 5 infectious disease, the easing of restrictions on activities and other measures, and the normalization of economic activity, further weakening the expression of COVID-19's impact on economic activity.
  3. FY2024-Q1SoftenedAnnual report

    「Although a gradual recovery trend is emerging as COVID-19 has been reclassified as a Category 5 infectious disease, restrictions on activities have been eased and economic activity has moved toward normalization,」

    The company describes the reclassification as a Category 5 infectious disease, the easing of restrictions on activities and the normalization of economic activity, further weakening the expression of COVID-19's impact on economic activity. It also states that there have been no material changes in assumptions regarding the timing of containment and other matters used in accounting estimates.
  4. FY2023SoftenedAnnual report

    「The company assumes that the impact on the group’s operating results is currently minor, partly because COVID-19 has been reclassified as a Category 5 infectious disease.」

    While concerns about a resurgence of infections remain, the wording has been softened to assume a minor current impact on operating results following the reclassification as a Category 5 infectious disease.
  5. FY2023-Q3RestatedAnnual report

    「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes in business and other risks, including COVID-19.
  6. FY2023-Q2RestatedAnnual report

    「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in business and other risks, including COVID-19.
  7. FY2023-Q1RestatedAnnual report

    「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in business and other risks, including COVID-19.
  8. FY2022RestatedAnnual report

    「The company states that COVID-19 may affect its business activities, financial position and operating results through employee infections.」

    The company continues to state that COVID-19 may affect its business activities, financial position and operating results through employee infections.
  9. FY2021WorsenedAnnual report

    「For the fiscal year, revenue decreased to ¥2,564.5 million, down 8.6% year on year. Although shipments of ethanol-related products increased due to the spread of COVID-19, shipment volumes of automotive-related and other products declined from the previous year, while domestic crude oil and naphtha market prices remained below the previous year's levels, causing the selling price per unit to fall.」

    The spread of COVID-19 affected full-year shipment volumes of automotive-related and other products, and revenue decreased 8.6% year on year.
  10. FY2021-Q3MaterialisedAnnual report

    「Although shipments of ethanol-related products increased due to the spread of COVID-19 and shipment volumes of automotive-related and other products were recovering, shipment volumes in the first and second quarters were lower than in the previous year. In addition, domestic crude oil and naphtha prices remained lower than in the previous year, causing selling prices to decline. Revenue therefore decreased 10.6% year on year to ¥19.087 billion.」

    The company states that the spread of COVID-19 contributed to the decline in shipment volumes of automotive-related and other products, resulting in revenue down 10.6% year on year.
  11. FY2021-Q2MaterialisedAnnual report

    「Revenue decreased to ¥1,243.4 million, down 13.1% year on year. Although shipments of ethanol-related products increased due to the spread of COVID-19, shipment volumes of automotive-related and other products, while showing signs of recovery, remained below the previous year, and domestic crude oil and naphtha market prices remained below the previous year's levels, causing the selling price per unit to fall.」

    The company states that the spread of COVID-19 contributed to the decline in shipment volumes of automotive-related and other products, resulting in revenue down 13.1% year on year.
  12. FY2021-Q1MaterialisedAnnual report

    「For the cumulative first quarter, revenue decreased to ¥634.3 million, down 11.3% year on year. Although shipments of ethanol-related products increased due to the spread of COVID-19, shipment volumes of automotive-related and other products declined, while domestic crude oil and naphtha market prices remained below the previous year's levels, causing the selling price per unit to fall.」

    The company states that the spread of COVID-19 contributed to the decline in shipment volumes of automotive-related and other products, resulting in revenue down 11.3% year on year. It also states that there were no material changes in assumptions regarding the future spread or containment timing of the infection used in accounting estimates.
  13. FY2020First statedAnnual report

    「The company states that COVID-19 may affect its business activities, financial position and operating results through a decline in shipment volumes caused by an economic slowdown and employee infections.」

    COVID-19 was explicitly identified for the first time as a standalone business and other risk, with the potential effects of lower shipment volumes and employee infections cited.
Moved together

"Foreign Exchange, Crude Oil and Naphtha Market Fluctuations" moved the same way as this thread, in the same document, in 8 of its 13 moves.

8522★1234
  1. ★This thread
  2. 1Foreign Exchange, Crude Oil and Naphtha Market Fluctuations8×
  3. 2Downturn in Overseas Economies and Intensifying Competition within the Industry5×
  4. 3Restrictions on raw-material supplies due to overseas supply-chain disruptions2×
  5. 4Development of New Solvent Markets and Business Areas2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Daishin Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.